Learning Objectives:

1)  Review adjuvant multidisciplinary strategies in early stage carcinosarcoma of the uterus, distinguishing this from management of uterine sarcoma.


2)  Discuss adjuvant management of high grade aggressive ovarian cancer histologies, specifically the evolving role of maintenance systemic options and appropriate application of germline/somatic testing.


3)  Appreciate nuanced adjuvant management of less common ovarian cancer histologies, such as malignant sex cord-stromal tumors and low grade serous carcinoma.


Session date: 
12/14/2021 - 7:00am to 8:00am CST
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
S. Diane Yamada, MD ; Katherine Kurnit, MD; Josephine Kim